Comparison of the clinical efficacy between single-agent and dual-agent concurrent chemoradiotherapy in the treatment of unresectable esophageal squamous cell carcinoma: a multicenter retrospective analysis

BACKGROUND: Some Chinese patients with esophageal squamous cell carcinomaare often treated with single-agent concurrent chemoradiotherapy. However, no results have been reported from randomized controlled clinical trials comparing single-agent with double-agent concurrent chemoradiotherapy. It there...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jie, Gong, Youling, Diao, Peng, Huang, Qingmei, Wen, Yixue, Lin, Binwei, Cai, Hongwei, Tian, Honggang, He, Bing, Ji, Lanlan, Guo, Ping, Miao, Jidong, Du, Xiaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778746/
https://www.ncbi.nlm.nih.gov/pubmed/29357883
http://dx.doi.org/10.1186/s13014-018-0958-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778746/
https://www.ncbi.nlm.nih.gov/pubmed/29357883
http://dx.doi.org/10.1186/s13014-018-0958-5

Ejemplares similares